Mon, April 13, 2009
Fri, April 10, 2009
Thu, April 9, 2009
Wed, April 8, 2009
Tue, April 7, 2009
Mon, April 6, 2009
Sun, April 5, 2009
Fri, April 3, 2009
Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Sun, March 29, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009

DSM N.V.: Final dividend 2008 Royal DSM N.V.


//business-finance.news-articles.net/content/200 .. 5/dsm-n-v-final-dividend-2008-royal-dsm-n-v.html
Published in Business and Finance on Wednesday, March 25th 2009 at 12:23 GMT, Last Modified on 2009-03-25 12:24:31 by Market Wire   Print publication without navigation


HEERLEN, NETHERLANDS--(Marketwire - March 25, 2009) -


The DSM Annual General Meeting of Shareholders on 25 March 2009 passed a resolution to declare a dividend for 2008 of EUR 1.20 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.40 per ordinary share having been paid on 22 August 2008, the final dividend for 2008 will amount to EUR 0.80 per ordinary share.

This final dividend of EUR 0.80 will be paid out entirely in cash, after deduction of 15% dividend tax, and will be made payable from 21 April 2009. The ex-dividend date on Euronext Amsterdam will be 27 March 2009.

Holders of registered shares listed in the register of shares kept by ANT will be informed by ANT about the payment to which they are entitled. Holders of shares held in a securities account will receive the final dividend through their bank or broker in whose custody the shares are held on 31 March 2009 at the close of business (record date). The dividend will be made payable to them through the intermediary of ABN AMRO Bank N.V acting under the name of RBS ("RBS") in Amsterdam (Netherlands).

RBS is offering all DSM shareholders the option to participate in the dividend reinvestment plan (DRIP). For more information see the Investors section at [ www.dsm.com ].

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: [ www.dsm.com ]

 For more information: DSM Corporate Communications DSM Investor Relations Herman Betten Hans Vossen tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864 fax +31 (0) 45 5740680 fax +31 (0) 45 5782595 e-mail [ media.relations@dsm.com ] e-mail [ investor.relations@dsm.com ]


Press release-pdf: [ http://hugin.info/130663/R/1300477/296947.pdf ]


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.


Copyright © Hugin AS 2009. All rights reserved.


Publication Contributing Sources